| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |